Home > Browse Research > Life Sciences > Pharmaceuticals

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

Anesthesia (15)

Biopharmaceuticals (366)

Biosimilars (130)

Biopharmacology (32)

Clinical Nutrition (41)

Clinical Trial (1010)

Country Overviews (881)

Dietary Supplements (1017)

Diseases & Conditions (3413)

Drug Delivery (342)

Transdermal & Implantable (46)

Drug Discovery (6328)

General Pharmaceuticals (553)

Generics Drugs (442)

Manufacturing, Packaging & Detailing (3040)

Over-the-Counter Drugs (3353)

Pharmaceuticals Company Reports (15103)

Pharmacy & Distribution (180)

Prescription Drugs (1864)

Pricing (258)

Regulation & Policy (486)

Research & Development (1553)

Technology (88)

Therapeutic Area (7481)

Vaccines (626)

Cancer Vaccines (155)
Pandemic Vaccines (83)

Pharmaceuticals market research reports and industry analysis

China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi 5/20/2013 \| published by: Access China Management Consulting Ltd. ... a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese drug authorities to administer the ... \| read more...	$750.00
Assured Pharmacy, Inc. - Company Capsule 5/18/2013 \| published by: Canadean Ltd ... major products and services, financial ratios, key competitors, financial analysis as well as key employees. Summary This report is a crucial resource for industry executives and anyone looking to access key information about Assured Pharmacy, ... \| read more...	$99.00
ICT Spend Predictions in Medium-sized Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/18/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
Just the Berries Ltd.: Ingredients - Company Profile & SWOT Report 5/18/2013 \| published by: Canadean Ltd ... its operations. The profile contains a company overview, key facts, major products and services, swot analysis, business description, company history, key employees, company locations and subsidiaries as well as employee biographies. Summary This report is ... \| read more...	$125.00
ICT Spend Predictions in Small Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/18/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Large Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/18/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Large Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/17/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Medium-sized US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/17/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Small US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/17/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Medium-sized Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/17/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Small German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/16/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Medium-sized Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/16/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Large Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/16/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Small Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/16/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Large US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/16/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013 5/15/2013 \| published by: Business Monitor International ... are many challenges to doing business inthe country, not least the presence of substandard drugs, lack of trained healthcare personnel, weak IPframework and supply chain concerns (such as a lack of suitable storage facilities in ... \| read more...	$1,295.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 5/15/2013 \| published by: Business Monitor International ... a downside risk to the future growthpotential of the pharmaceutical industry. Headline Expenditure Projections Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.38bn (US$510mn) in 2013; +24.0% inlocal currency terms with a contraction of -6.8% in US ... \| read more...	$1,295.00
Croatia Pharmaceuticals and Healthcare Report Q3 2013 5/15/2013 \| published by: Business Monitor International ... thecountry's economy. The Croatian pharmaceutical market continues to pose a challenging environment todomestic and international drugmakers, but we believe EU accession will ease the regulatory burden aslegislation is harmonised with EU norms. In 2013 the ... \| read more...	$1,295.00
Japan Pharmaceuticals and Healthcare Report Q3 2013 5/15/2013 \| published by: Business Monitor International ... looking to expand in the country. Meanwhile, domestic firms willcontinue to expand overseas (especially in emerging markets) in order to maintain revenue growth. Headline Expenditure Projections Pharmaceuticals: JPY10,358bn (US$129.7) in 2012 to JPY10,823bn (US$118.9bn) in ... \| read more...	$1,295.00
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 5/15/2013 \| published by: Business Monitor International ... burden over the next two decades -continuing to limit revenue earning opportunities for companies whose product portfolios containmedicines for the treatment of long-term diseases. Headline Expenditure Projections Pharmaceuticals: PKR189.21bn (US$2.03bn) in 2012 to PRK209.65bn (US2.11bn) ... \| read more...	$1,295.00
ICT Spend Predictions in Medium-sized French Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/15/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Small French Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/15/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Large German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/15/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Medium-sized German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/15/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00
ICT Spend Predictions in Small UK Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 5/14/2013 \| published by: Kable ... areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting. Summary Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model ... \| read more...	$495.00

< prev 1 2 3 4 5 6 7 8 9 10 next >